PACB
Pacific Biosciences of California, Inc.
LABORATORY ANALYTICAL INSTRUMENTS
Best Lab Instruments Stocks 2026 →
PACB Stock Analysis: Buy, Sell, or Hold?
$2.24
-0.12 (-5.08%)
âŧ
5d:
-8.2%
30d:
+6.67%
90d:
+101.8%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect PACB Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (45%)
Quality Score
40/100
Position
FAIR
30-Day Fair Range
$2.02 â $2.63
Position: FAIR
Forward P/E & Valuation
-5.4x
Next 12M consensus est.
Wall Street Target
$2.74
+22.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.12 / $3.07
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PACB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $2.24, which is considered fair relative to its 30-day fair value range of $2.02 to $2.63.
Technical Outlook: Technically, PACB is in a strong uptrend. Immediate support is located at $2.12, while resistance sits at $3.06. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: PACB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.74 (+22.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACB is in a strong uptrend. Immediate support is located at $2.12, while resistance sits at $3.06. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: PACB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.74 (+22.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.02 -
$2.63
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.7%
Trading Range & Key Levels
30-Day Trading Range
$2.02 -
$2.63
Current vs Trading Range
FAIR
Support Level
$2.12
Resistance Level
$3.07
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding PACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 22.5% below Wall St target ($2.74)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.37
Wall Street Target
$2.74
(+22.5%)
Revenue Growth (YoY)
5.5%
Profit Margin
-81.3%
Share PACB Analysis
Share this live PACB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PACB)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
A user on StockTwits shared a link to Pacific Biosciences of California, Inc.'s (PACB) latest SEC filing regarding a passive investment. The filing shows an increase in institutional ownership.
Key Retail Themes:
institutional ownership
passive investment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:59 AM ET
Data refreshes hourly during market hours. Next update: 5:59 AM
Data refreshes hourly during market hours. Next update: 5:59 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PACB Research Pages
